Intentional re-challenge and the clinical data management of Drug Related problems
•
0 likes•29 views
Intentional re-challenge, a practice within clinical data management, is a deliberate and controlled re-administration of a drug to a patient who has previously experienced an adverse drug reaction or drug-related problem during the course of a clinical trial. This process is undertaken to confirm the causality between the drug and the observed adverse event, gain a deeper understanding of the event's mechanisms, and assess the potential for its recurrence. Clinical data management plays a pivotal role in documenting and tracking these intentional re-challenges, meticulously recording patient information, medical history, dosage regimens, and the nature and severity of the adverse event. The data management process ensures that the re-challenge is conducted in a controlled and ethical manner, with a keen focus on patient safety. This comprehensive data management approach aids in evaluating the drug's safety profile, informing regulatory decisions, and ultimately contributing to the overall pharmacovigilance and risk assessment of the drug under investigation.
Report
Share
Report
Share
Download to read offline
Recommended
Role of Clinical Data Management in Risk-Based Monitoring
Clinical Data Management (CDM) plays a significant role in the implementation of Risk-Based Monitoring (RBM) within clinical trials. RBM is an approach that focuses monitoring efforts on areas of highest risk, thereby optimizing resource allocation, enhancing data quality, and ensuring patient safety. Here's how CDM contributes to RBM
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptx
Risk-Based Monitoring (RBM) in clinical trials represents a departure from traditional, one-size-fits-all monitoring approaches. This innovative strategy tailors monitoring activities to the specific risks associated with a trial, optimizing resource utilization and enhancing data quality. This article explores the key principles, benefits, and challenges of RBM, illustrating its transformative impact on the landscape of clinical trial oversight.
Key Principles:
Risk Identification and Assessment:
RBM begins with a comprehensive assessment of potential risks to data integrity, patient safety, and study endpoints. These risks are identified based on factors such as study complexity, patient population, and investigational product characteristics.
Clinical Data Management in the Era of Precision Medicine
Clinical data management plays a critical role in the era of precision medicine by ensuring the quality, integrity, and accessibility of data used in research and healthcare. Precision medicine aims to tailor medical interventions to individual patients based on their unique genetic, environmental, and lifestyle characteristics. Here are some key considerations for clinical data management in the era of precision medicine
Role of Clinical Data Management in Clinical Research
Clinical data management (CDM) plays a critical role in clinical research by ensuring the accuracy, completeness, and consistency of clinical trial data. Here are some key roles and responsibilities of CDM in clinical research:
Data collection: CDM is responsible for designing and implementing data collection procedures to ensure that all data is collected in a standardized and consistent manner.
Data quality control: CDM is responsible for implementing quality control procedures to ensure that data is accurate, complete, and consistent across all study sites.
Data cleaning: CDM is responsible for identifying and resolving data discrepancies or errors in the data that may impact the analysis of study results.
Data analysis: CDM is responsible for performing statistical analyses of the data collected in the clinical trial, which are used to evaluate the safety and efficacy of the investigational product.
Database management: CDM is responsible for developing and maintaining the study database, which is used to store and manage all data collected in the clinical trial.
Study documentation: CDM is responsible for ensuring that all study documentation is accurate, complete, and up-to-date, including study protocols, data collection forms, and standard operating procedures.
Compliance with regulatory requirements: CDM is responsible for ensuring that all data collected in the clinical trial is compliant with regulatory requirements and industry standards
Best Practices for Data Collection and Management in Clinical Trials
Data collection and management in clinical trials are crucial for ensuring the accuracy, integrity, and reliability of study findings. Here are some best practices for data collection and management in clinical trials:
Standardized Data Collection: Use standardized data collection tools, such as electronic case report forms (eCRFs), to ensure consistent and uniform data capture across study sites. Clearly define data fields, formats, and coding conventions to minimize variability and errors.
Training and Standard Operating Procedures (SOPs): Provide comprehensive training to study personnel on data collection procedures, including proper documentation, data entry, and quality control measures. Develop and implement SOPs that outline data collection, handling, and storage processes.
Source Data Verification (SDV): Perform regular source data verification to ensure the accuracy and completeness of data. Compare data entered in the eCRFs with original source documents (e.g., medical records, laboratory reports) to identify discrepancies and resolve any inconsistencies.
Data Quality Checks: Implement automated data quality checks to identify potential errors, outliers, and inconsistencies in the data. Range checks, logic checks, and consistency checks can help identify data entry errors or missing data points.
Data Security and Confidentiality: Implement robust data security measures to protect participant confidentiality and comply with data protection regulations. Use secure servers, encryption techniques, and access controls to prevent unauthorized access and ensure data privacy.
Data Monitoring and Audit Trails: Establish a data monitoring plan to regularly review and validate data for accuracy and completeness. Maintain an audit trail that tracks any changes made to the data, including the date, time, and reason for modifications.
Data Backup and Storage: Implement regular data backup procedures to prevent data loss. Store data securely and ensure appropriate backup storage to mitigate risks associated with data corruption or system failures.
The Role of Artificial Intelligence and Machine Learning in Clinical Data Man...
Clinical Data Management (CDM) is a complex and data-intensive process that plays a critical role in clinical research and the development of new medical treatments. It involves the collection, cleaning, validation, and management of clinical trial data to ensure its accuracy and compliance with regulatory standards. In recent years, the healthcare and pharmaceutical industries have witnessed the transformative impact of artificial intelligence (AI) and machine learning (ML) technologies on CDM.
Clinical Data Management importance in Clinical Trials
Clinical data management (CDM) is a crucial component of clinical trials that involves the collection, processing, validation, and management of data generated during the course of a clinical study. It plays a vital role in ensuring the accuracy, integrity, and quality of the data collected, which is essential for reliable analysis and interpretation of study results. Here are some key reasons highlighting the importance of clinical data management in clinical trials:
Data Integrity: CDM focuses on maintaining the integrity of the data collected during a clinical trial. This involves applying standardized data collection methods, implementing data validation checks, and ensuring data accuracy, completeness, and consistency. By maintaining data integrity, CDM helps minimize errors, reduce bias, and enhance the reliability and credibility of study findings.
Compliance with Regulatory Requirements: Clinical trials are subject to stringent regulatory guidelines and standards. CDM ensures that the collected data meets these requirements, including adherence to Good Clinical Practice (GCP) guidelines, data privacy regulations, and relevant industry-specific standards. Proper data management practices facilitate regulatory inspections and audits, demonstrating the compliance of the study with applicable regulations.
Efficient Data Handling: CDM streamlines the process of data collection, entry, and management. It involves the development of data collection forms (e.g., electronic Case Report Forms - eCRFs), database design, and data validation procedures. Efficient data handling processes minimize data discrepancies, reduce manual errors, and improve data quality, ultimately leading to more accurate and reliable study results.
Quality Control and Data Cleaning: CDM includes quality control measures to identify and resolve discrepancies, missing data, or inconsistencies in the collected data. Data cleaning activities involve cross-checking and resolving any discrepancies or outliers, ensuring data accuracy and completeness. This process enhances data quality, minimizing the potential impact of data errors on study outcomes.
Database Lock and Analysis: CDM plays a vital role in the database lock process, where the final study database is considered "locked" and no further data modifications are allowed. Database lock is a critical step before statistical analysis and reporting. Proper CDM practices ensure that the database is complete, accurate, and ready for analysis, enabling researchers to generate valid and meaningful results.
Data Security and Confidentiality: CDM incorporates measures to ensure the security and confidentiality of participant data. This includes implementing data access controls, data encryption, and adherence to data protection regulations. Protecting participant privacy and maintaining data security are crucial for building trust with study participants and complying with legal and ethical requirements.
Data Traceability and
Database Designing in Clinical Data Management
When designing a Clinical Data Management (CDM) database, several key considerations should be taken into account to ensure efficient data capture, storage, and retrieval. Here are some important aspects to consider in CDM database design:
Define Study Requirements:
Understand the specific requirements of the study and the data to be collected. This includes variables, data types, formats, and any specific rules or calculations required for data validation and derivation. Consult with the study team and stakeholders to determine the necessary data elements.
Data Model Design:
Develop a data model that represents the structure and relationships of the data. Use standard data models, such as CDISC (Clinical Data Interchange Standards Consortium) standards, as a foundation. Define entities (e.g., patients, visits, assessments) and attributes (e.g., demographics, lab results) and establish relationships between them.
Data Dictionary:
Create a comprehensive data dictionary that provides a detailed description of each data element, including its name, definition, data type, length, format, allowable values, and any validation or derivation rules. The data dictionary serves as a reference for data entry and validation checks.
Database Schema:
Design the database schema based on the data model and data dictionary. Identify the tables, fields, and relationships needed to store the data. Determine primary and foreign keys to establish relationships between tables. Normalize the schema to reduce redundancy and improve data integrity.
Data Capture Forms:
Design user-friendly data capture forms to facilitate efficient and accurate data entry. Align the form layout with the data model and data dictionary. Include necessary data validation checks and provide clear instructions or prompts for data entry.
Data Validation and Quality Checks:
Incorporate data validation checks to ensure data accuracy and completeness. Implement range checks, format checks, consistency checks, and logic checks to identify and prevent data entry errors. Include data quality control processes to identify and resolve data discrepancies or anomalies.
Security and Access Controls:
Implement appropriate security measures to protect the confidentiality, integrity, and availability of the data. Define user roles and access levels to control data access and modification. Employ encryption, authentication, and audit trails to ensure data security and compliance with regulatory requirements.
Data Extraction and Reporting:
Consider the need for data extraction and reporting capabilities. Design mechanisms to extract data from the database for analysis or reporting purposes. Implement data export functionalities in commonly used formats, such as CSV or Excel, or integrate with reporting tools or systems.
Recommended
Role of Clinical Data Management in Risk-Based Monitoring
Clinical Data Management (CDM) plays a significant role in the implementation of Risk-Based Monitoring (RBM) within clinical trials. RBM is an approach that focuses monitoring efforts on areas of highest risk, thereby optimizing resource allocation, enhancing data quality, and ensuring patient safety. Here's how CDM contributes to RBM
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptx
Risk-Based Monitoring (RBM) in clinical trials represents a departure from traditional, one-size-fits-all monitoring approaches. This innovative strategy tailors monitoring activities to the specific risks associated with a trial, optimizing resource utilization and enhancing data quality. This article explores the key principles, benefits, and challenges of RBM, illustrating its transformative impact on the landscape of clinical trial oversight.
Key Principles:
Risk Identification and Assessment:
RBM begins with a comprehensive assessment of potential risks to data integrity, patient safety, and study endpoints. These risks are identified based on factors such as study complexity, patient population, and investigational product characteristics.
Clinical Data Management in the Era of Precision Medicine
Clinical data management plays a critical role in the era of precision medicine by ensuring the quality, integrity, and accessibility of data used in research and healthcare. Precision medicine aims to tailor medical interventions to individual patients based on their unique genetic, environmental, and lifestyle characteristics. Here are some key considerations for clinical data management in the era of precision medicine
Role of Clinical Data Management in Clinical Research
Clinical data management (CDM) plays a critical role in clinical research by ensuring the accuracy, completeness, and consistency of clinical trial data. Here are some key roles and responsibilities of CDM in clinical research:
Data collection: CDM is responsible for designing and implementing data collection procedures to ensure that all data is collected in a standardized and consistent manner.
Data quality control: CDM is responsible for implementing quality control procedures to ensure that data is accurate, complete, and consistent across all study sites.
Data cleaning: CDM is responsible for identifying and resolving data discrepancies or errors in the data that may impact the analysis of study results.
Data analysis: CDM is responsible for performing statistical analyses of the data collected in the clinical trial, which are used to evaluate the safety and efficacy of the investigational product.
Database management: CDM is responsible for developing and maintaining the study database, which is used to store and manage all data collected in the clinical trial.
Study documentation: CDM is responsible for ensuring that all study documentation is accurate, complete, and up-to-date, including study protocols, data collection forms, and standard operating procedures.
Compliance with regulatory requirements: CDM is responsible for ensuring that all data collected in the clinical trial is compliant with regulatory requirements and industry standards
Best Practices for Data Collection and Management in Clinical Trials
Data collection and management in clinical trials are crucial for ensuring the accuracy, integrity, and reliability of study findings. Here are some best practices for data collection and management in clinical trials:
Standardized Data Collection: Use standardized data collection tools, such as electronic case report forms (eCRFs), to ensure consistent and uniform data capture across study sites. Clearly define data fields, formats, and coding conventions to minimize variability and errors.
Training and Standard Operating Procedures (SOPs): Provide comprehensive training to study personnel on data collection procedures, including proper documentation, data entry, and quality control measures. Develop and implement SOPs that outline data collection, handling, and storage processes.
Source Data Verification (SDV): Perform regular source data verification to ensure the accuracy and completeness of data. Compare data entered in the eCRFs with original source documents (e.g., medical records, laboratory reports) to identify discrepancies and resolve any inconsistencies.
Data Quality Checks: Implement automated data quality checks to identify potential errors, outliers, and inconsistencies in the data. Range checks, logic checks, and consistency checks can help identify data entry errors or missing data points.
Data Security and Confidentiality: Implement robust data security measures to protect participant confidentiality and comply with data protection regulations. Use secure servers, encryption techniques, and access controls to prevent unauthorized access and ensure data privacy.
Data Monitoring and Audit Trails: Establish a data monitoring plan to regularly review and validate data for accuracy and completeness. Maintain an audit trail that tracks any changes made to the data, including the date, time, and reason for modifications.
Data Backup and Storage: Implement regular data backup procedures to prevent data loss. Store data securely and ensure appropriate backup storage to mitigate risks associated with data corruption or system failures.
The Role of Artificial Intelligence and Machine Learning in Clinical Data Man...
Clinical Data Management (CDM) is a complex and data-intensive process that plays a critical role in clinical research and the development of new medical treatments. It involves the collection, cleaning, validation, and management of clinical trial data to ensure its accuracy and compliance with regulatory standards. In recent years, the healthcare and pharmaceutical industries have witnessed the transformative impact of artificial intelligence (AI) and machine learning (ML) technologies on CDM.
Clinical Data Management importance in Clinical Trials
Clinical data management (CDM) is a crucial component of clinical trials that involves the collection, processing, validation, and management of data generated during the course of a clinical study. It plays a vital role in ensuring the accuracy, integrity, and quality of the data collected, which is essential for reliable analysis and interpretation of study results. Here are some key reasons highlighting the importance of clinical data management in clinical trials:
Data Integrity: CDM focuses on maintaining the integrity of the data collected during a clinical trial. This involves applying standardized data collection methods, implementing data validation checks, and ensuring data accuracy, completeness, and consistency. By maintaining data integrity, CDM helps minimize errors, reduce bias, and enhance the reliability and credibility of study findings.
Compliance with Regulatory Requirements: Clinical trials are subject to stringent regulatory guidelines and standards. CDM ensures that the collected data meets these requirements, including adherence to Good Clinical Practice (GCP) guidelines, data privacy regulations, and relevant industry-specific standards. Proper data management practices facilitate regulatory inspections and audits, demonstrating the compliance of the study with applicable regulations.
Efficient Data Handling: CDM streamlines the process of data collection, entry, and management. It involves the development of data collection forms (e.g., electronic Case Report Forms - eCRFs), database design, and data validation procedures. Efficient data handling processes minimize data discrepancies, reduce manual errors, and improve data quality, ultimately leading to more accurate and reliable study results.
Quality Control and Data Cleaning: CDM includes quality control measures to identify and resolve discrepancies, missing data, or inconsistencies in the collected data. Data cleaning activities involve cross-checking and resolving any discrepancies or outliers, ensuring data accuracy and completeness. This process enhances data quality, minimizing the potential impact of data errors on study outcomes.
Database Lock and Analysis: CDM plays a vital role in the database lock process, where the final study database is considered "locked" and no further data modifications are allowed. Database lock is a critical step before statistical analysis and reporting. Proper CDM practices ensure that the database is complete, accurate, and ready for analysis, enabling researchers to generate valid and meaningful results.
Data Security and Confidentiality: CDM incorporates measures to ensure the security and confidentiality of participant data. This includes implementing data access controls, data encryption, and adherence to data protection regulations. Protecting participant privacy and maintaining data security are crucial for building trust with study participants and complying with legal and ethical requirements.
Data Traceability and
Database Designing in Clinical Data Management
When designing a Clinical Data Management (CDM) database, several key considerations should be taken into account to ensure efficient data capture, storage, and retrieval. Here are some important aspects to consider in CDM database design:
Define Study Requirements:
Understand the specific requirements of the study and the data to be collected. This includes variables, data types, formats, and any specific rules or calculations required for data validation and derivation. Consult with the study team and stakeholders to determine the necessary data elements.
Data Model Design:
Develop a data model that represents the structure and relationships of the data. Use standard data models, such as CDISC (Clinical Data Interchange Standards Consortium) standards, as a foundation. Define entities (e.g., patients, visits, assessments) and attributes (e.g., demographics, lab results) and establish relationships between them.
Data Dictionary:
Create a comprehensive data dictionary that provides a detailed description of each data element, including its name, definition, data type, length, format, allowable values, and any validation or derivation rules. The data dictionary serves as a reference for data entry and validation checks.
Database Schema:
Design the database schema based on the data model and data dictionary. Identify the tables, fields, and relationships needed to store the data. Determine primary and foreign keys to establish relationships between tables. Normalize the schema to reduce redundancy and improve data integrity.
Data Capture Forms:
Design user-friendly data capture forms to facilitate efficient and accurate data entry. Align the form layout with the data model and data dictionary. Include necessary data validation checks and provide clear instructions or prompts for data entry.
Data Validation and Quality Checks:
Incorporate data validation checks to ensure data accuracy and completeness. Implement range checks, format checks, consistency checks, and logic checks to identify and prevent data entry errors. Include data quality control processes to identify and resolve data discrepancies or anomalies.
Security and Access Controls:
Implement appropriate security measures to protect the confidentiality, integrity, and availability of the data. Define user roles and access levels to control data access and modification. Employ encryption, authentication, and audit trails to ensure data security and compliance with regulatory requirements.
Data Extraction and Reporting:
Consider the need for data extraction and reporting capabilities. Design mechanisms to extract data from the database for analysis or reporting purposes. Implement data export functionalities in commonly used formats, such as CSV or Excel, or integrate with reporting tools or systems.
Workflow of CDM
Clinical Data Management (CDM) is a critical component of clinical research that involves the collection, cleaning, validation, and management of clinical trial data to ensure its accuracy, integrity, and compliance with regulatory requirements. The workflow of CDM typically consists of several key stages, each with specific activities and processes. Here is an overview of the typical workflow of CDM:
Study Startup:
Protocol Review: CDM teams begin by reviewing the clinical trial protocol to understand the study's objectives, endpoints, data collection requirements, and timelines.
Database Design: Based on the protocol, the team designs a data capture system or electronic data capture (EDC) system. This includes creating data entry forms, defining data validation checks, and setting up data dictionaries.
Data Collection:
Case Report Form (CRF) Design: CDM professionals design electronic or paper CRFs to collect data during the trial. CRFs capture specific data points required by the protocol.
Data Entry: Data is entered into the CRFs, either electronically by site personnel or through paper CRFs.
Data Validation: CDM teams implement validation checks to ensure data quality and consistency. Data validation checks may include range checks, consistency checks, and logic checks.
Query Management: Queries are generated when data discrepancies or inconsistencies are identified. CDM teams send queries to investigational sites for resolution.
Data Cleaning and Quality Control:
Data Cleaning: Data are cleaned to resolve discrepancies, discrepancies, and inconsistencies. This involves querying data discrepancies with clinical trial sites.
Data Review: CDM teams review data to ensure completeness and accuracy, and any outstanding queries are resolved.
Quality Control: Quality control processes are applied to verify the integrity and accuracy of data.
Database Lock:
Once the data are cleaned, reviewed, and validated, the database is locked, indicating that no further changes can be made to the data. Database lock is a critical step before data analysis begins.
Data Export and Analysis:
Data is exported from the database and provided to biostatisticians and researchers for statistical analysis. This analysis is conducted to determine the study's outcomes, efficacy, and safety profile.
Data listings, summaries, and tables are generated for regulatory submissions, reports, and publications.
Final Study Reporting:
After data analysis, CDM teams contribute to the preparation of final study reports, which provide a comprehensive overview of the trial's results, data quality, and regulatory compliance.
Archiving and Documentation:
Clinical trial data, documentation, and databases are archived to ensure their long-term availability for regulatory audits and future reference.
Regulatory Submission: CDM teams provide support for regulatory submissions.
Database Designing in CDM
Database design in the context of Clinical Data Management (CDM) is a crucial aspect of organizing and managing clinical trial data effectively and efficiently. A well-designed database ensures that data collected during a clinical trial is accurate, consistent, and accessible, facilitating data analysis, reporting, and regulatory submissions. Clinical Data Management involves various steps, including data collection, validation, cleaning, and reporting
The impact of real world data in pharmacovilgilance and regulatory decision m...
Real-world data (RWD) has revolutionized the field of pharmacovigilance and regulatory decision-making. While clinical trials provide valuable insights into the safety and efficacy of medications, RWD offers a comprehensive view of a drug's performance in real-world settings. In this blog post, we will explore the significant impact of RWD in pharmacovigilance and how it has transformed the way regulatory decisions are made. We will discuss the benefits of utilizing RWD, the challenges associated with its implementation, and its potential to improve patient safety and healthcare outcomes.
Clinical data security and Integrity in Clinical Research
Clinical data security and integrity are paramount in maintaining patient confidentiality, protecting sensitive medical information, and ensuring the reliability of healthcare data. Security measures encompass various strategies and technologies aimed at safeguarding clinical data from unauthorized access, breaches, or manipulation.
Encryption techniques, access controls, and secure authentication mechanisms are commonly employed to restrict access to patient records and prevent unauthorized individuals from viewing or altering sensitive data. Additionally, robust network security protocols, such as firewalls and intrusion detection systems, help safeguard against external threats and cyberattacks targeting healthcare systems.
Enhancing Data Quality in Clinical Trials: Best Practices and Quality Control...
Ensuring data quality is crucial in clinical trials to generate reliable and valid results. High-quality data allows for accurate analysis, interpretation, and decision-making regarding the safety and efficacy of investigational products. Here are some best practices and quality control measures to enhance data quality in clinical trials:
Standardized Data Collection: Implement standardized data collection procedures, including the use of case report forms (CRFs) or electronic data capture (EDC) systems. Clearly define data elements, variables, and measurement scales to minimize inconsistencies and errors in data entry.
Training and Education: Provide comprehensive training to investigators, site staff, and data entry personnel on the protocol, data collection procedures, and Good Clinical Practice (GCP) guidelines. Training ensures understanding and adherence to the study requirements, leading to accurate and consistent data collection.
Source Data Verification (SDV): Perform source data verification to compare data recorded in the CRFs or EDC systems with the original source documents (e.g., medical records, laboratory reports). This process helps identify discrepancies, errors, or missing data, ensuring data accuracy and integrity.
Data Management Plan: Develop a robust data management plan that outlines procedures for data collection, handling, storage, and analysis. The plan should include data validation checks, query resolution processes, and data reconciliation between different data sources.
Electronic Data Capture (EDC) Systems: Utilize EDC systems to facilitate real-time data capture, improve data accuracy, and streamline data management processes. EDC systems often have built-in data validation checks, range checks, and skip patterns to minimize data entry errors.
CLINICAL DATA MANAGEMENT- AN OVERVIEW
Clinical data management (CDM) is a process that involves the collection, cleaning, and management of data from clinical trials. The goal of CDM is to ensure that the data collected in a study is accurate, complete, and consistent, and that it complies with regulatory requirements and industry standards.
CDM involves several key activities, including:
Data collection: This involves collecting data from various sources, such as electronic medical records, case report forms, and laboratory results. The data must be collected in a standardized and consistent manner to ensure that it is reliable and can be used for analysis.
Data cleaning: This involves identifying and resolving errors or inconsistencies in the data. This may involve checking for missing or incomplete data, verifying the accuracy of the data, and resolving any discrepancies or inconsistencies.
Data validation: This involves verifying that the data meets regulatory requirements and industry standards. This includes checking that the data is consistent with the study protocol, that it has been collected and recorded accurately, and that it is complete and reliable.
Data management: This involves storing and managing the data in a secure and organized manner. The data must be protected from unauthorized access or disclosure and must be available for analysis and reporting.
Effective CDM is critical for ensuring the validity and reliability of clinical trial data. It helps to ensure that the data collected is accurate, complete, and consistent, which ultimately leads to more reliable study results. Additionally, effective CDM helps to ensure compliance with regulatory requirements and industry standards, which is essential for gaining regulatory approval for new medical interventions.
Clinical Data Management Process Overview_Katalyst HLS
Introduction to Clinical Data Management Process Overview in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Pharmacovigilance Auditing: Ensuring Data Integrity and Compliance
Pharmacovigilance auditing is a crucial process within the pharmaceutical industry that focuses on ensuring data integrity and compliance with regulatory requirements related to drug safety and adverse event reporting. It involves systematic and independent assessments of pharmacovigilance systems, processes, and documentation to verify their accuracy, consistency, and adherence to established standards.
Key Objectives of Pharmacovigilance Auditing:
Data Integrity: Auditing aims to ensure the accuracy, completeness, and reliability of pharmacovigilance data. This includes confirming that adverse event reports are properly collected, documented, and stored, and that data manipulation or unauthorized alterations do not occur.
Regulatory Compliance: Audits help ensure that pharmacovigilance activities are in accordance with applicable regulations and guidelines, such as those set forth by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other relevant health authorities.
Process Validation: Auditing assesses the effectiveness of pharmacovigilance processes, such as signal detection, risk assessment, and benefit-risk analysis. It helps verify that these processes are robust, consistently applied, and appropriately documented.
Quality Management System Evaluation: Auditing evaluates the overall quality management system of a pharmaceutical company, including organizational structure, roles and responsibilities, training programs, and documentation practices related to pharmacovigilance.
Vendor Audits: Companies often outsource certain pharmacovigilance activities to third-party vendors. Auditing these vendors ensures they meet the same high standards for data integrity and regulatory compliance.
Continuous Improvement: Auditing identifies areas for improvement within pharmacovigilance systems and processes. It provides valuable insights that can be used to enhance procedures, address deficiencies, and prevent future issues.
Machine Learning Algorithms for Predictive Analytics in Precision Medicine
The integration of machine learning algorithms for predictive analytics in precision medicine represents a powerful tool for extracting meaningful insights from diverse and complex datasets. As the field continues to evolve, these algorithms play a crucial role in advancing our understanding of individualized treatment strategies, improving patient outcomes, and ultimately shaping the future of personalized healthcare.
merging trends in Clinical Research: Exploring the latest Innovations
Clinical research is an evolving field, and several emerging trends and innovations are shaping its future. These trends are driven by advancements in technology, changes in regulatory landscapes, and the need for more efficient and patient-centered research. Here are some of the latest innovations and trends in clinical research
Signal detection and their assessment in clinical trials
Signal detection in clinical trials is a crucial aspect of pharmacovigilance that involves identifying potential safety concerns or signals associated with the use of investigational drugs. The process of signal detection is ongoing throughout the life cycle of a drug, from early-phase trials to post-marketing surveillance. Here's an overview of signal detection and the assessment process in clinical trials
Clinical Data Management: Best Practices and Key Considerations
Clinical data management (CDM) is a critical component of clinical research, involving the collection, processing, and analysis of data generated during clinical trials. Implementing best practices and considering key considerations is essential for ensuring data quality, integrity, and regulatory compliance. Here are some important considerations and best practices in clinical data management:
Data Standardization: Standardizing data collection and documentation across study sites is crucial for ensuring consistency and facilitating data analysis. Develop standardized data collection forms, case report forms (CRFs), and electronic data capture (EDC) systems that capture relevant data elements in a consistent manner.
Data Validation and Quality Control: Implement robust data validation procedures to ensure the accuracy and completeness of collected data. Conduct thorough quality control checks, including data validation checks, range checks, and consistency checks, to identify and resolve data discrepancies or errors.
Data Security and Privacy: Ensure data security and protect participant privacy by implementing appropriate measures such as data encryption, secure data transfer protocols, access controls, and adherence to applicable data protection regulations like GDPR or HIPAA.
Data Monitoring and Cleaning: Regularly monitor data collection processes to identify and address data discrepancies, missing data, or outliers. Implement data cleaning procedures to identify and resolve data errors, inconsistencies, and outliers that may impact the integrity and reliability of the study data.
Data Traceability and Audit Trail: Maintain a comprehensive audit trail that captures all changes and activities related to data entry, data modifications, and data review. This ensures data traceability and facilitates data validation and regulatory inspections.
Standard Operating Procedures (SOPs): Develop and adhere to well-defined SOPs for data management activities. SOPs should cover all aspects of data collection, processing, validation, cleaning, and archiving, ensuring consistency and adherence to regulatory requirements.
Integration of Clinical Trial Systems: Enhancing Collaboration and Efficiency
Clinical trials are complex endeavors that involve numerous stakeholders, vast datasets, and intricate processes. To streamline operations, enhance collaboration, and improve efficiency, the integration of clinical trial systems has emerged as a pivotal solution. This strategic approach involves connecting various components, such as electronic data capture (EDC) systems, clinical trial management systems (CTMS), and electronic health records (EHR), fostering a cohesive ecosystem that accelerates the pace of research and ensures data accuracy.
Data Management and Analysis in Clinical Trials
Data management and analysis play a critical role in the successful conduct of clinical trials. Proper collection, validation, and handling of data are essential for ensuring the reliability and integrity of study findings. Data management involves the design and implementation of data capture tools, such as electronic case report forms eCRFs, to efficiently collect and store clinical data. Additionally, data analysis is a crucial step that involves applying statistical methods to extract meaningful insights from the collected data. This paper provides an overview of the key components of data management and analysis in clinical trials, highlighting the importance of adherence to data standards, ensuring data quality, and maintaining data security. Effective data management and analysis not only lead to robust study outcomes but also contribute to the overall advancement of medical knowledge and patient care. S. Reddemma | Chetana Menda | Manoj Kumar "Data Management and Analysis in Clinical Trials" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-4, August 2023, URL: https://www.ijtsrd.com/papers/ijtsrd59667.pdf Paper Url:https://www.ijtsrd.com/pharmacy/pharmacology-/59667/data-management-and-analysis-in-clinical-trials/s-reddemma
Decentralized clinical trials.pptx
A decentralized clinical trial (DCT) is an innovative approach to conducting clinical research that leverages digital technologies and remote processes to enable greater patient participation and data collection outside of traditional clinical trial settings. In a decentralized trial, participants have the flexibility to engage in the study from their own homes or local healthcare facilities, reducing the need for frequent visits to centralized trial sites.
The key features of decentralized clinical trials include:
Remote Participant Engagement: DCTs utilize various digital tools and platforms to facilitate participant engagement. This may involve virtual visits, telemedicine consultations, electronic informed consent, and remote monitoring of participants' health status and adherence to study protocols.
Mobile and Wearable Technologies: Mobile devices and wearable sensors play a significant role in decentralized trials. They enable real-time data collection, including vital signs, patient-reported outcomes, medication adherence, and other relevant health data. These technologies enhance convenience for participants while providing continuous, objective data for researchers.
Virtual Study Operations: DCTs employ virtual tools for study management and coordination. These include electronic data capture systems, online study training, remote monitoring of data quality, and electronic trial master files. Virtual platforms facilitate seamless communication between study teams, investigators, and participants.
Local Healthcare Providers: In decentralized trials, local healthcare providers or clinical research sites often play a more substantial role in participant recruitment, enrollment, and follow-up. These providers may be responsible for conducting study visits, collecting samples, and implementing study interventions, while ensuring compliance with the trial protocol.
Data Security and Privacy: Protecting participant data and maintaining privacy are critical in decentralized trials. Robust data security measures, such as encryption, secure data transmission, and compliance with privacy regulations like GDPR or HIPAA, are implemented to safeguard participants' sensitive information.
The Changing Landscape of Clinical Research Regulations: Updates and Implicat...
The landscape of clinical research regulations is constantly evolving to adapt to the changing needs of the research community, advancements in scientific understanding, and the protection of research participants. Here are some key updates and implications that have shaped the current state of clinical research regulations
4222020 Originality Reporthttpsucumberlands.blackboar.docx
4/22/2020 Originality Report
https://ucumberlands.blackboard.com/webapps/mdb-sa-BB5a31b16bb2c48/originalityReport/ultra?attemptId=c27f66fc-c5df-47dc-9f48-d005b34b35d9… 1/4
%59
%0
SafeAssign Originality Report
Spring 2020 - Data Science & Big Data Analy (ITS-836-9) - Second Bi-T… • Final Exam (project)
%59Total Score: High riskNaveeda Reddy Anugu
Submission UUID: eb75ebf8-071b-3035-cadd-c5c1220ab248
Total Number of Reports
1
Highest Match
59 %
Final.pptx
Average Match
59 %
Submitted on
04/22/20
10:09 PM CDT
Average Word Count
1,130
Highest: Final.pptx
%59Attachment 1
Institutional database (6)
Student paper Student paper Student paper
Student paper Student paper Student paper
Internet (1)
hospitalcareers
Top sources (3)
Excluded sources (0)
View Originality Report - Old Design
Word Count: 1,130
Final.pptx
2 7 5
6 1 3
4
2 Student paper 7 Student paper 5 Student paper
FINAL SPONSOR PRESENTATION
Naveeda Reddy Anugu
University of the Cumberlands
Professor: Dr Kelly Wibbenmeyer
DATE: 04/22/2020
SITUATION
The hospital intends to utilize patient data gathers to enhance the health of its members and offer services at relatively lower costs
This is in response to patients’ previous complaints about the high cost of treatment and associated low health results
The impacts points toward ineffective treatment plans and harmful prescription of medication to susceptible populations
Data collected include diseases treated and billed for, prescriptions were given, and the types of treatments given
The data may be used in big data analytics to enhance treatment options, customize patients’ risks and to support customized treatment intervention
Advanced and frontier big data analytics has the potential to improve health. Data can be used to distinguish between effective and ineffective medical practices
depending on an individual patient. Aetna, is a company that collects data for more than 20 million customers and from its pilot project studies, it is evident that
health institutions can promote health and reduce costs by utilizing Big Data Analytics. 2
PROJECT GOALS
The project entails unveiling an invention that will permit big data analytics to buttress decisions and intervention in healthcare settings
The aim of the intervention include: Creation of patient centered decision making support systems
1
2
3
4
2
https://ucumberlands.blackboard.com/webapps/mdb-sa-BB5a31b16bb2c48/originalityReport?attemptId=c27f66fc-c5df-47dc-9f48-d005b34b35d9&course_id=_114115_1&download=true&includeDeleted=true&print=true&force=true
4/22/2020 Originality Report
https://ucumberlands.blackboard.com/webapps/mdb-sa-BB5a31b16bb2c48/originalityReport/ultra?attemptId=c27f66fc-c5df-47dc-9f48-d005b34b35d9… 2/4
The aim of the intervention include: Creation of patient-centered decision making support systems
Utilization of patient's data contained in clinical trails, insurance companies records and in patient’s health reco.
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Data integrity can be implemented using several approaches. One of the most effective ways to implement DI is a risk based approach. The speaker elaborates this.
Role of Drug Regulatory agencies in Clinical Research.
Drug regulatory agencies play a pivotal role in overseeing and regulating clinical research to ensure the safety, efficacy, and quality of pharmaceutical products. Their primary responsibility is to protect public health by evaluating the data generated from clinical trials and determining whether a drug can be approved for marketing and use in patients. Here are some key roles of drug regulatory agencies in clinical research:
Approval and Oversight of Clinical Trials: Regulatory agencies review and approve clinical trial protocols, ensuring that they adhere to ethical and scientific standards. They assess the design, methodology, and objectives of trials to ensure patient safety and the reliability of data generated.
Regulatory Guidance and Standards: These agencies provide guidance and establish regulations governing the conduct of clinical trials, including Good Clinical Practice (GCP) guidelines, which outline standards for trial design, conduct, monitoring, and reporting.
Review and Evaluation of Data: Regulatory agencies review the data collected from clinical trials to assess the safety and efficacy of investigational drugs. They evaluate study results, adverse events, and other relevant information to make informed decisions about drug approval.
Drug Approval and Labeling: Based on the evaluation of clinical trial data, regulatory agencies decide whether to approve a drug for marketing and use. They also determine the appropriate labeling, including indications, dosages, contraindications, and warnings, to ensure safe and effective use by healthcare professionals and patients.
Post-Marketing Surveillance: Regulatory agencies continue to monitor the safety and effectiveness of approved drugs through post-marketing surveillance programs. They collect and analyze real-world data on adverse events and drug utilization to identify potential risks and take appropriate regulatory actions if safety concerns arise.
Enforcement of Regulations: Regulatory agencies enforce compliance with regulatory requirements and take enforcement actions against sponsors, investigators, or manufacturers who fail to adhere to ethical or regulatory standards in clinical research.
International Collaboration: Many regulatory agencies collaborate with counterparts in other countries to harmonize regulatory standards, exchange information, and streamline the drug approval process, facilitating global drug development and access to new therapies.
Data Privacy and consent management .. .
Data privacy and consent management are critical aspects of ensuring that individuals' personal information is handled responsibly and ethically, particularly in healthcare settings where sensitive medical data is involved. Data privacy refers to the protection of personal information from unauthorized access, use, or disclosure, while consent management involves obtaining and managing individuals' permissions for the collection, storage, and processing of their data.
In healthcare, patients entrust providers with their sensitive medical information, expecting that it will be kept confidential and used only for legitimate purposes related to their care. Robust data privacy measures include encryption, access controls, and anonymization techniques to safeguard patient data from unauthorized access or breaches. Additionally, healthcare organizations must adhere to regulatory standards such as HIPAA in the United States or GDPR in the European Union, which outline specific requirements for the protection of patient information and impose penalties for non-compliance.
Consent management plays a crucial role in ensuring that individuals have control over how their data is used. Patients should be informed about the purposes for which their data will be collected and processed, as well as any potential risks or benefits associated with its use. Obtaining informed consent involves providing individuals with clear and transparent information about their privacy rights and giving them the opportunity to consent to or decline the use of their data for specific purposes. Consent management systems help healthcare organizations track and manage patients' consent preferences, ensuring that data is used in accordance with their wishes and legal requirements.
Effective data privacy and consent management practices not only protect individuals' privacy rights but also foster trust and transparency in healthcare relationships. By implementing robust security measures, respecting patients' autonomy, and promoting informed decision-making, healthcare organizations can uphold the principles of data privacy and consent while leveraging data responsibly to improve patient care and outcomes.
More Related Content
Similar to Intentional re-challenge and the clinical data management of Drug Related problems
Workflow of CDM
Clinical Data Management (CDM) is a critical component of clinical research that involves the collection, cleaning, validation, and management of clinical trial data to ensure its accuracy, integrity, and compliance with regulatory requirements. The workflow of CDM typically consists of several key stages, each with specific activities and processes. Here is an overview of the typical workflow of CDM:
Study Startup:
Protocol Review: CDM teams begin by reviewing the clinical trial protocol to understand the study's objectives, endpoints, data collection requirements, and timelines.
Database Design: Based on the protocol, the team designs a data capture system or electronic data capture (EDC) system. This includes creating data entry forms, defining data validation checks, and setting up data dictionaries.
Data Collection:
Case Report Form (CRF) Design: CDM professionals design electronic or paper CRFs to collect data during the trial. CRFs capture specific data points required by the protocol.
Data Entry: Data is entered into the CRFs, either electronically by site personnel or through paper CRFs.
Data Validation: CDM teams implement validation checks to ensure data quality and consistency. Data validation checks may include range checks, consistency checks, and logic checks.
Query Management: Queries are generated when data discrepancies or inconsistencies are identified. CDM teams send queries to investigational sites for resolution.
Data Cleaning and Quality Control:
Data Cleaning: Data are cleaned to resolve discrepancies, discrepancies, and inconsistencies. This involves querying data discrepancies with clinical trial sites.
Data Review: CDM teams review data to ensure completeness and accuracy, and any outstanding queries are resolved.
Quality Control: Quality control processes are applied to verify the integrity and accuracy of data.
Database Lock:
Once the data are cleaned, reviewed, and validated, the database is locked, indicating that no further changes can be made to the data. Database lock is a critical step before data analysis begins.
Data Export and Analysis:
Data is exported from the database and provided to biostatisticians and researchers for statistical analysis. This analysis is conducted to determine the study's outcomes, efficacy, and safety profile.
Data listings, summaries, and tables are generated for regulatory submissions, reports, and publications.
Final Study Reporting:
After data analysis, CDM teams contribute to the preparation of final study reports, which provide a comprehensive overview of the trial's results, data quality, and regulatory compliance.
Archiving and Documentation:
Clinical trial data, documentation, and databases are archived to ensure their long-term availability for regulatory audits and future reference.
Regulatory Submission: CDM teams provide support for regulatory submissions.
Database Designing in CDM
Database design in the context of Clinical Data Management (CDM) is a crucial aspect of organizing and managing clinical trial data effectively and efficiently. A well-designed database ensures that data collected during a clinical trial is accurate, consistent, and accessible, facilitating data analysis, reporting, and regulatory submissions. Clinical Data Management involves various steps, including data collection, validation, cleaning, and reporting
The impact of real world data in pharmacovilgilance and regulatory decision m...
Real-world data (RWD) has revolutionized the field of pharmacovigilance and regulatory decision-making. While clinical trials provide valuable insights into the safety and efficacy of medications, RWD offers a comprehensive view of a drug's performance in real-world settings. In this blog post, we will explore the significant impact of RWD in pharmacovigilance and how it has transformed the way regulatory decisions are made. We will discuss the benefits of utilizing RWD, the challenges associated with its implementation, and its potential to improve patient safety and healthcare outcomes.
Clinical data security and Integrity in Clinical Research
Clinical data security and integrity are paramount in maintaining patient confidentiality, protecting sensitive medical information, and ensuring the reliability of healthcare data. Security measures encompass various strategies and technologies aimed at safeguarding clinical data from unauthorized access, breaches, or manipulation.
Encryption techniques, access controls, and secure authentication mechanisms are commonly employed to restrict access to patient records and prevent unauthorized individuals from viewing or altering sensitive data. Additionally, robust network security protocols, such as firewalls and intrusion detection systems, help safeguard against external threats and cyberattacks targeting healthcare systems.
Enhancing Data Quality in Clinical Trials: Best Practices and Quality Control...
Ensuring data quality is crucial in clinical trials to generate reliable and valid results. High-quality data allows for accurate analysis, interpretation, and decision-making regarding the safety and efficacy of investigational products. Here are some best practices and quality control measures to enhance data quality in clinical trials:
Standardized Data Collection: Implement standardized data collection procedures, including the use of case report forms (CRFs) or electronic data capture (EDC) systems. Clearly define data elements, variables, and measurement scales to minimize inconsistencies and errors in data entry.
Training and Education: Provide comprehensive training to investigators, site staff, and data entry personnel on the protocol, data collection procedures, and Good Clinical Practice (GCP) guidelines. Training ensures understanding and adherence to the study requirements, leading to accurate and consistent data collection.
Source Data Verification (SDV): Perform source data verification to compare data recorded in the CRFs or EDC systems with the original source documents (e.g., medical records, laboratory reports). This process helps identify discrepancies, errors, or missing data, ensuring data accuracy and integrity.
Data Management Plan: Develop a robust data management plan that outlines procedures for data collection, handling, storage, and analysis. The plan should include data validation checks, query resolution processes, and data reconciliation between different data sources.
Electronic Data Capture (EDC) Systems: Utilize EDC systems to facilitate real-time data capture, improve data accuracy, and streamline data management processes. EDC systems often have built-in data validation checks, range checks, and skip patterns to minimize data entry errors.
CLINICAL DATA MANAGEMENT- AN OVERVIEW
Clinical data management (CDM) is a process that involves the collection, cleaning, and management of data from clinical trials. The goal of CDM is to ensure that the data collected in a study is accurate, complete, and consistent, and that it complies with regulatory requirements and industry standards.
CDM involves several key activities, including:
Data collection: This involves collecting data from various sources, such as electronic medical records, case report forms, and laboratory results. The data must be collected in a standardized and consistent manner to ensure that it is reliable and can be used for analysis.
Data cleaning: This involves identifying and resolving errors or inconsistencies in the data. This may involve checking for missing or incomplete data, verifying the accuracy of the data, and resolving any discrepancies or inconsistencies.
Data validation: This involves verifying that the data meets regulatory requirements and industry standards. This includes checking that the data is consistent with the study protocol, that it has been collected and recorded accurately, and that it is complete and reliable.
Data management: This involves storing and managing the data in a secure and organized manner. The data must be protected from unauthorized access or disclosure and must be available for analysis and reporting.
Effective CDM is critical for ensuring the validity and reliability of clinical trial data. It helps to ensure that the data collected is accurate, complete, and consistent, which ultimately leads to more reliable study results. Additionally, effective CDM helps to ensure compliance with regulatory requirements and industry standards, which is essential for gaining regulatory approval for new medical interventions.
Clinical Data Management Process Overview_Katalyst HLS
Introduction to Clinical Data Management Process Overview in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Pharmacovigilance Auditing: Ensuring Data Integrity and Compliance
Pharmacovigilance auditing is a crucial process within the pharmaceutical industry that focuses on ensuring data integrity and compliance with regulatory requirements related to drug safety and adverse event reporting. It involves systematic and independent assessments of pharmacovigilance systems, processes, and documentation to verify their accuracy, consistency, and adherence to established standards.
Key Objectives of Pharmacovigilance Auditing:
Data Integrity: Auditing aims to ensure the accuracy, completeness, and reliability of pharmacovigilance data. This includes confirming that adverse event reports are properly collected, documented, and stored, and that data manipulation or unauthorized alterations do not occur.
Regulatory Compliance: Audits help ensure that pharmacovigilance activities are in accordance with applicable regulations and guidelines, such as those set forth by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other relevant health authorities.
Process Validation: Auditing assesses the effectiveness of pharmacovigilance processes, such as signal detection, risk assessment, and benefit-risk analysis. It helps verify that these processes are robust, consistently applied, and appropriately documented.
Quality Management System Evaluation: Auditing evaluates the overall quality management system of a pharmaceutical company, including organizational structure, roles and responsibilities, training programs, and documentation practices related to pharmacovigilance.
Vendor Audits: Companies often outsource certain pharmacovigilance activities to third-party vendors. Auditing these vendors ensures they meet the same high standards for data integrity and regulatory compliance.
Continuous Improvement: Auditing identifies areas for improvement within pharmacovigilance systems and processes. It provides valuable insights that can be used to enhance procedures, address deficiencies, and prevent future issues.
Machine Learning Algorithms for Predictive Analytics in Precision Medicine
The integration of machine learning algorithms for predictive analytics in precision medicine represents a powerful tool for extracting meaningful insights from diverse and complex datasets. As the field continues to evolve, these algorithms play a crucial role in advancing our understanding of individualized treatment strategies, improving patient outcomes, and ultimately shaping the future of personalized healthcare.
merging trends in Clinical Research: Exploring the latest Innovations
Clinical research is an evolving field, and several emerging trends and innovations are shaping its future. These trends are driven by advancements in technology, changes in regulatory landscapes, and the need for more efficient and patient-centered research. Here are some of the latest innovations and trends in clinical research
Signal detection and their assessment in clinical trials
Signal detection in clinical trials is a crucial aspect of pharmacovigilance that involves identifying potential safety concerns or signals associated with the use of investigational drugs. The process of signal detection is ongoing throughout the life cycle of a drug, from early-phase trials to post-marketing surveillance. Here's an overview of signal detection and the assessment process in clinical trials
Clinical Data Management: Best Practices and Key Considerations
Clinical data management (CDM) is a critical component of clinical research, involving the collection, processing, and analysis of data generated during clinical trials. Implementing best practices and considering key considerations is essential for ensuring data quality, integrity, and regulatory compliance. Here are some important considerations and best practices in clinical data management:
Data Standardization: Standardizing data collection and documentation across study sites is crucial for ensuring consistency and facilitating data analysis. Develop standardized data collection forms, case report forms (CRFs), and electronic data capture (EDC) systems that capture relevant data elements in a consistent manner.
Data Validation and Quality Control: Implement robust data validation procedures to ensure the accuracy and completeness of collected data. Conduct thorough quality control checks, including data validation checks, range checks, and consistency checks, to identify and resolve data discrepancies or errors.
Data Security and Privacy: Ensure data security and protect participant privacy by implementing appropriate measures such as data encryption, secure data transfer protocols, access controls, and adherence to applicable data protection regulations like GDPR or HIPAA.
Data Monitoring and Cleaning: Regularly monitor data collection processes to identify and address data discrepancies, missing data, or outliers. Implement data cleaning procedures to identify and resolve data errors, inconsistencies, and outliers that may impact the integrity and reliability of the study data.
Data Traceability and Audit Trail: Maintain a comprehensive audit trail that captures all changes and activities related to data entry, data modifications, and data review. This ensures data traceability and facilitates data validation and regulatory inspections.
Standard Operating Procedures (SOPs): Develop and adhere to well-defined SOPs for data management activities. SOPs should cover all aspects of data collection, processing, validation, cleaning, and archiving, ensuring consistency and adherence to regulatory requirements.
Integration of Clinical Trial Systems: Enhancing Collaboration and Efficiency
Clinical trials are complex endeavors that involve numerous stakeholders, vast datasets, and intricate processes. To streamline operations, enhance collaboration, and improve efficiency, the integration of clinical trial systems has emerged as a pivotal solution. This strategic approach involves connecting various components, such as electronic data capture (EDC) systems, clinical trial management systems (CTMS), and electronic health records (EHR), fostering a cohesive ecosystem that accelerates the pace of research and ensures data accuracy.
Data Management and Analysis in Clinical Trials
Data management and analysis play a critical role in the successful conduct of clinical trials. Proper collection, validation, and handling of data are essential for ensuring the reliability and integrity of study findings. Data management involves the design and implementation of data capture tools, such as electronic case report forms eCRFs, to efficiently collect and store clinical data. Additionally, data analysis is a crucial step that involves applying statistical methods to extract meaningful insights from the collected data. This paper provides an overview of the key components of data management and analysis in clinical trials, highlighting the importance of adherence to data standards, ensuring data quality, and maintaining data security. Effective data management and analysis not only lead to robust study outcomes but also contribute to the overall advancement of medical knowledge and patient care. S. Reddemma | Chetana Menda | Manoj Kumar "Data Management and Analysis in Clinical Trials" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-4, August 2023, URL: https://www.ijtsrd.com/papers/ijtsrd59667.pdf Paper Url:https://www.ijtsrd.com/pharmacy/pharmacology-/59667/data-management-and-analysis-in-clinical-trials/s-reddemma
Decentralized clinical trials.pptx
A decentralized clinical trial (DCT) is an innovative approach to conducting clinical research that leverages digital technologies and remote processes to enable greater patient participation and data collection outside of traditional clinical trial settings. In a decentralized trial, participants have the flexibility to engage in the study from their own homes or local healthcare facilities, reducing the need for frequent visits to centralized trial sites.
The key features of decentralized clinical trials include:
Remote Participant Engagement: DCTs utilize various digital tools and platforms to facilitate participant engagement. This may involve virtual visits, telemedicine consultations, electronic informed consent, and remote monitoring of participants' health status and adherence to study protocols.
Mobile and Wearable Technologies: Mobile devices and wearable sensors play a significant role in decentralized trials. They enable real-time data collection, including vital signs, patient-reported outcomes, medication adherence, and other relevant health data. These technologies enhance convenience for participants while providing continuous, objective data for researchers.
Virtual Study Operations: DCTs employ virtual tools for study management and coordination. These include electronic data capture systems, online study training, remote monitoring of data quality, and electronic trial master files. Virtual platforms facilitate seamless communication between study teams, investigators, and participants.
Local Healthcare Providers: In decentralized trials, local healthcare providers or clinical research sites often play a more substantial role in participant recruitment, enrollment, and follow-up. These providers may be responsible for conducting study visits, collecting samples, and implementing study interventions, while ensuring compliance with the trial protocol.
Data Security and Privacy: Protecting participant data and maintaining privacy are critical in decentralized trials. Robust data security measures, such as encryption, secure data transmission, and compliance with privacy regulations like GDPR or HIPAA, are implemented to safeguard participants' sensitive information.
The Changing Landscape of Clinical Research Regulations: Updates and Implicat...
The landscape of clinical research regulations is constantly evolving to adapt to the changing needs of the research community, advancements in scientific understanding, and the protection of research participants. Here are some key updates and implications that have shaped the current state of clinical research regulations
4222020 Originality Reporthttpsucumberlands.blackboar.docx
4/22/2020 Originality Report
https://ucumberlands.blackboard.com/webapps/mdb-sa-BB5a31b16bb2c48/originalityReport/ultra?attemptId=c27f66fc-c5df-47dc-9f48-d005b34b35d9… 1/4
%59
%0
SafeAssign Originality Report
Spring 2020 - Data Science & Big Data Analy (ITS-836-9) - Second Bi-T… • Final Exam (project)
%59Total Score: High riskNaveeda Reddy Anugu
Submission UUID: eb75ebf8-071b-3035-cadd-c5c1220ab248
Total Number of Reports
1
Highest Match
59 %
Final.pptx
Average Match
59 %
Submitted on
04/22/20
10:09 PM CDT
Average Word Count
1,130
Highest: Final.pptx
%59Attachment 1
Institutional database (6)
Student paper Student paper Student paper
Student paper Student paper Student paper
Internet (1)
hospitalcareers
Top sources (3)
Excluded sources (0)
View Originality Report - Old Design
Word Count: 1,130
Final.pptx
2 7 5
6 1 3
4
2 Student paper 7 Student paper 5 Student paper
FINAL SPONSOR PRESENTATION
Naveeda Reddy Anugu
University of the Cumberlands
Professor: Dr Kelly Wibbenmeyer
DATE: 04/22/2020
SITUATION
The hospital intends to utilize patient data gathers to enhance the health of its members and offer services at relatively lower costs
This is in response to patients’ previous complaints about the high cost of treatment and associated low health results
The impacts points toward ineffective treatment plans and harmful prescription of medication to susceptible populations
Data collected include diseases treated and billed for, prescriptions were given, and the types of treatments given
The data may be used in big data analytics to enhance treatment options, customize patients’ risks and to support customized treatment intervention
Advanced and frontier big data analytics has the potential to improve health. Data can be used to distinguish between effective and ineffective medical practices
depending on an individual patient. Aetna, is a company that collects data for more than 20 million customers and from its pilot project studies, it is evident that
health institutions can promote health and reduce costs by utilizing Big Data Analytics. 2
PROJECT GOALS
The project entails unveiling an invention that will permit big data analytics to buttress decisions and intervention in healthcare settings
The aim of the intervention include: Creation of patient centered decision making support systems
1
2
3
4
2
https://ucumberlands.blackboard.com/webapps/mdb-sa-BB5a31b16bb2c48/originalityReport?attemptId=c27f66fc-c5df-47dc-9f48-d005b34b35d9&course_id=_114115_1&download=true&includeDeleted=true&print=true&force=true
4/22/2020 Originality Report
https://ucumberlands.blackboard.com/webapps/mdb-sa-BB5a31b16bb2c48/originalityReport/ultra?attemptId=c27f66fc-c5df-47dc-9f48-d005b34b35d9… 2/4
The aim of the intervention include: Creation of patient-centered decision making support systems
Utilization of patient's data contained in clinical trails, insurance companies records and in patient’s health reco.
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Data integrity can be implemented using several approaches. One of the most effective ways to implement DI is a risk based approach. The speaker elaborates this.
Similar to Intentional re-challenge and the clinical data management of Drug Related problems (20)
The impact of real world data in pharmacovilgilance and regulatory decision m...
The impact of real world data in pharmacovilgilance and regulatory decision m...
Clinical data security and Integrity in Clinical Research
Clinical data security and Integrity in Clinical Research
Enhancing Data Quality in Clinical Trials: Best Practices and Quality Control...
Enhancing Data Quality in Clinical Trials: Best Practices and Quality Control...
Clinical Data Management Process Overview_Katalyst HLS
Clinical Data Management Process Overview_Katalyst HLS
Pharmacovigilance Auditing: Ensuring Data Integrity and Compliance
Pharmacovigilance Auditing: Ensuring Data Integrity and Compliance
Machine Learning Algorithms for Predictive Analytics in Precision Medicine
Machine Learning Algorithms for Predictive Analytics in Precision Medicine
merging trends in Clinical Research: Exploring the latest Innovations
merging trends in Clinical Research: Exploring the latest Innovations
Signal detection and their assessment in clinical trials
Signal detection and their assessment in clinical trials
Clinical Data Management: Best Practices and Key Considerations
Clinical Data Management: Best Practices and Key Considerations
Integration of Clinical Trial Systems: Enhancing Collaboration and Efficiency
Integration of Clinical Trial Systems: Enhancing Collaboration and Efficiency
The Changing Landscape of Clinical Research Regulations: Updates and Implicat...
The Changing Landscape of Clinical Research Regulations: Updates and Implicat...
4222020 Originality Reporthttpsucumberlands.blackboar.docx
4222020 Originality Reporthttpsucumberlands.blackboar.docx
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
More from ClinosolIndia
Role of Drug Regulatory agencies in Clinical Research.
Drug regulatory agencies play a pivotal role in overseeing and regulating clinical research to ensure the safety, efficacy, and quality of pharmaceutical products. Their primary responsibility is to protect public health by evaluating the data generated from clinical trials and determining whether a drug can be approved for marketing and use in patients. Here are some key roles of drug regulatory agencies in clinical research:
Approval and Oversight of Clinical Trials: Regulatory agencies review and approve clinical trial protocols, ensuring that they adhere to ethical and scientific standards. They assess the design, methodology, and objectives of trials to ensure patient safety and the reliability of data generated.
Regulatory Guidance and Standards: These agencies provide guidance and establish regulations governing the conduct of clinical trials, including Good Clinical Practice (GCP) guidelines, which outline standards for trial design, conduct, monitoring, and reporting.
Review and Evaluation of Data: Regulatory agencies review the data collected from clinical trials to assess the safety and efficacy of investigational drugs. They evaluate study results, adverse events, and other relevant information to make informed decisions about drug approval.
Drug Approval and Labeling: Based on the evaluation of clinical trial data, regulatory agencies decide whether to approve a drug for marketing and use. They also determine the appropriate labeling, including indications, dosages, contraindications, and warnings, to ensure safe and effective use by healthcare professionals and patients.
Post-Marketing Surveillance: Regulatory agencies continue to monitor the safety and effectiveness of approved drugs through post-marketing surveillance programs. They collect and analyze real-world data on adverse events and drug utilization to identify potential risks and take appropriate regulatory actions if safety concerns arise.
Enforcement of Regulations: Regulatory agencies enforce compliance with regulatory requirements and take enforcement actions against sponsors, investigators, or manufacturers who fail to adhere to ethical or regulatory standards in clinical research.
International Collaboration: Many regulatory agencies collaborate with counterparts in other countries to harmonize regulatory standards, exchange information, and streamline the drug approval process, facilitating global drug development and access to new therapies.
Data Privacy and consent management .. .
Data privacy and consent management are critical aspects of ensuring that individuals' personal information is handled responsibly and ethically, particularly in healthcare settings where sensitive medical data is involved. Data privacy refers to the protection of personal information from unauthorized access, use, or disclosure, while consent management involves obtaining and managing individuals' permissions for the collection, storage, and processing of their data.
In healthcare, patients entrust providers with their sensitive medical information, expecting that it will be kept confidential and used only for legitimate purposes related to their care. Robust data privacy measures include encryption, access controls, and anonymization techniques to safeguard patient data from unauthorized access or breaches. Additionally, healthcare organizations must adhere to regulatory standards such as HIPAA in the United States or GDPR in the European Union, which outline specific requirements for the protection of patient information and impose penalties for non-compliance.
Consent management plays a crucial role in ensuring that individuals have control over how their data is used. Patients should be informed about the purposes for which their data will be collected and processed, as well as any potential risks or benefits associated with its use. Obtaining informed consent involves providing individuals with clear and transparent information about their privacy rights and giving them the opportunity to consent to or decline the use of their data for specific purposes. Consent management systems help healthcare organizations track and manage patients' consent preferences, ensuring that data is used in accordance with their wishes and legal requirements.
Effective data privacy and consent management practices not only protect individuals' privacy rights but also foster trust and transparency in healthcare relationships. By implementing robust security measures, respecting patients' autonomy, and promoting informed decision-making, healthcare organizations can uphold the principles of data privacy and consent while leveraging data responsibly to improve patient care and outcomes.
Pharmacovigilance in Patriatics and Geriatrics
Pharmacovigilance in pediatrics and geriatrics is of paramount importance due to the unique physiological and pharmacokinetic characteristics of these populations. In pediatrics, factors such as rapid growth, organ maturation, and differences in drug metabolism can influence the safety and efficacy of medications. Therefore, monitoring for adverse drug reactions (ADRs), including both known and unexpected effects, is crucial in ensuring the safe use of drugs in children. Additionally, since pediatric patients often receive off-label or unlicensed medications due to limited clinical trials in this population, pharmacovigilance efforts play a critical role in gathering real-world data to inform pediatric drug use.
Presenting- Signal mining in Pharmacovigilance
Signal mining in pharmacovigilance involves the systematic analysis of large datasets to identify potential safety signals associated with medications. It encompasses a variety of computational and statistical methods aimed at detecting patterns or trends that may indicate previously unrecognized adverse drug reactions (ADRs). Signal mining relies on data from sources such as spontaneous reporting systems, electronic health records, clinical trials, and medical literature. Advanced algorithms and data mining techniques, including disproportionality analysis, Bayesian data mining, and machine learning, are employed to sift through vast amounts of data to uncover potential signals of concern. These signals are then subjected to further evaluation to determine their clinical relevance and potential impact on patient safety. By leveraging the power of big data and analytics, signal mining plays a crucial role in enhancing pharmacovigilance efforts, enabling proactive identification and mitigation of medication-related risks, and ultimately contributing to improved patient care and drug safety.
Patient centered Pharmacovigilance .. .
Patient-centered pharmacovigilance represents a pivotal shift in the landscape of healthcare, emphasizing the active involvement of patients in the monitoring and reporting of adverse drug reactions. Unlike traditional pharmacovigilance, which primarily relies on healthcare professionals to identify and document adverse events, this approach recognizes patients as critical stakeholders in ensuring medication safety. By empowering patients to share their experiences, concerns, and observations regarding medication effects, whether positive or negative, healthcare systems can gain a comprehensive understanding of drug safety and efficacy in real-world settings. Patient-centered pharmacovigilance fosters a collaborative partnership between patients, healthcare providers, and regulatory agencies, promoting transparency, accountability, and ultimately, better patient outcomes. Through increased patient engagement and the utilization of patient-reported data, this approach enables healthcare systems to identify potential safety issues earlier, tailor treatment strategies to individual needs, and enhance overall drug safety surveillance efforts.
Introduction to Blogs, Presentations and Review Articles- Noorush Shifa Nizami
Blogs, presentations, and review articles stand as dynamic mediums, each with its unique power to engage, inform, and influence. Blogs, the conversational storytellers; presentations, the visual orchestrators; and review articles, the comprehensive knowledge curators, collectively play pivotal roles in shaping how we share, learn, and explore diverse subjects. This exploration delves into the distinct characteristics and purposes of these forms of communication, unveiling the art of effective expression and knowledge sharing in the digital age.
Patient-Centric Approaches in Precision Medicine Trials: Strategies for Success
Precision medicine, with its focus on tailoring medical treatment to the individual characteristics of each patient, has ushered in a new era in healthcare. Within this paradigm, clinical trials play a pivotal role in testing and validating targeted therapies. This article explores the importance of adopting patient-centric approaches in precision medicine trials and outlines strategies to enhance their success. By prioritizing patient engagement, leveraging digital technologies, and fostering collaborative partnerships, precision medicine trials can not only advance scientific understanding but also ensure that patient perspectives and experiences are integral to the research process.
Collaborative Initiatives: How Patient Advocacy Groups Contribute to the Succ...
Collaborative initiatives involving patient advocacy groups play a crucial role in advancing the success of precision medicine. Precision medicine, also known as personalized medicine, tailors medical treatment and interventions to the characteristics of each patient, considering factors such as genetic makeup, lifestyle, and environment. Patient advocacy groups contribute to the success of precision medicine in several ways:
Raising Awareness and Education:
Patient advocacy groups are instrumental in raising awareness about precision medicine among their communities.
They provide education and resources to patients, caregivers, and the general public, promoting a better understanding of the benefits and implications of precision medicine.
Patient Empowerment:
Advocacy groups empower patients by providing them with information about their conditions and treatment options.
They help patients understand the importance of participating in precision medicine initiatives, including clinical trials and genetic testing.
Supporting Research and Development:
Patient advocacy groups often collaborate with researchers and industry stakeholders to support the development of targeted therapies and diagnostics.
By actively participating in research initiatives, advocacy groups contribute to the identification of genetic markers, biomarkers, and other factors that influence treatment response.
Influencing Policy and Regulation:
Advocacy groups advocate for policies that support the advancement of precision medicine.
They work to ensure that regulations promote patient access to personalized treatments and protect patient rights, privacy, and data security.
Fostering Collaboration:
Patient advocacy groups facilitate collaboration among patients, researchers, healthcare providers, and industry partners.
They create platforms for sharing information, experiences, and best practices, fostering a collaborative environment that accelerates progress in precision medicine.
Clinical Trial Recruitment:
Advocacy groups play a crucial role in recruiting patients for clinical trials related to precision medicine.
Their engagement helps ensure diverse and representative participant populations, leading to more robust and applicable research outcomes.
Feedback and Patient-Centric Approaches:
Advocacy groups provide valuable feedback on the patient experience, preferences, and priorities.
This patient-centric approach helps researchers and healthcare professionals tailor precision medicine strategies to better meet the needs and expectations of the individuals they serve.
Championing Access to Treatments:
Patient advocacy groups work to improve patient access to precision medicine treatments.
They advocate for affordable and equitable access to innovative therapies, ensuring that the benefits of precision medicine are accessible to a broader population.
In summary, patient advocacy groups play a multifaceted role in advancing precision medicine by fostering awareness,
Ethical Dilemmas in Precision Medicine: Navigating the Intersection of Scienc...
The Ethical dilemmas in precision medicine arise from balancing the potential benefits of tailored treatments with concerns about privacy, consent, equity, and the implications of genetic information. These Dilemmas include issues around informed consent for data sharing, ensuring equitable access to precision medicine technologies, and safeguarding against discrimination based on Information. The potential for misuse or unintended consequences further complicate the ethical landscape of precision medicine. The Precision medicine widely used in Data Integration, Biomarkers, Targeted Therapies, predictive modeling, Clinical Decision Support. Precision Medicine improves the Patient outcomes, enhancing treatment efficacy, and reducing healthcare costs by minimizing trial and error in treatment selection. The precision medicine also raises Ethical legal and social complications related to data privacy, consent and equitable access and the potential for Discrimination based on information.
Regulatory Considerations in Precision Medicine: Navigating the Approval Process
Precision medicine, with its focus on tailoring medical treatments to individual characteristics, presents unique regulatory challenges in the drug development and approval process. This ppt delves into the regulatory considerations associated with precision medicine, exploring the key aspects that pharmaceutical and biotechnology companies need to navigate
Emerging Technologies and Tools in Precision Medicine Research
Precision medicine has witnessed significant advancements with the integration of emerging technologies and innovative tools. This abstract explores the current landscape of precision medicine research, focusing on the role of cutting-edge technologies and tools in revolutionizing healthcare approaches.
Precision Medicine in Action: Case Studies and Success Stories
Precision medicine, an innovative approach tailoring medical treatment to individual characteristics, holds great promise for improved patient outcomes. In this paradigm, pharmacovigilance plays a crucial role in monitoring and ensuring the safety of personalized treatments. The integration of big data and artificial intelligence (AI) into pharmacovigilance practices becomes paramount for handling the complexities of individualized therapies and identifying potential safety concerns. This article explores the synergies between big data, AI, and pharmacovigilance in the context of precision medicine.
Harnessing Big Data and Artificial Intelligence for Pharmacovigilance in Prec...
Precision medicine, an innovative approach tailoring medical treatment to individual characteristics, holds great promise for improved patient outcomes. In this paradigm, pharmacovigilance plays a crucial role in monitoring and ensuring the safety of personalized treatments. The integration of big data and artificial intelligence (AI) into pharmacovigilance practices becomes paramount for handling the complexities of individualized therapies and identifying potential safety concerns. This article explores the synergies between big data, AI, and pharmacovigilance in the context of precision medicine.
Pharmacovigilance (PV) Companies: Ensuring Drug Safety in Personalized Treatm...
Pharmacovigilance, a critical component of the healthcare and pharmaceutical industry, plays a pivotal role in monitoring and ensuring the safety of drugs. As personalized treatment approaches gain prominence, the responsibilities of PV companies become even more significant. This article explores the key functions of pharmacovigilance companies in the context of personalized medicine, focusing on their role in ensuring drug safety and mitigating potential risks associated with tailored therapeutic interventions.
Adoptive Design: Optimizing Clinical Trial Strategies for Precision Medicine
Clinical trials play a pivotal role in advancing medical research and ensuring the efficacy of new treatments. In the context of precision medicine, where therapies are tailored to individual characteristics, adaptive design emerges as a powerful strategy to optimize clinical trial outcomes. This approach deviates from traditional fixed trial designs, allowing for modifications based on accumulating data, thus enhancing efficiency, flexibility, and the likelihood of success in precision medicine endeavors.
Artificial Intelligence In Clinical Trial
Clinical trials are a cornerstone of medical research, paving the way for new treatments and advancements in healthcare. In recent years, Artificial Intelligence (AI) has emerged as a transformative force, reshaping the landscape of clinical trials. This article explores the various ways in which AI is revolutionizing the design, execution, and analysis of clinical trials.
Emerging Technologies Shaping the Future of Precision Medicine
Precision medicine, with its focus on tailoring healthcare interventions to individual characteristics, is undergoing a transformative evolution propelled by emerging technologies. From advanced genomic tools to artificial intelligence, these technologies are revolutionizing our ability to understand, diagnose, and treat diseases at an unprecedented level of specificity. This article explores the key emerging technologies shaping the future of precision medicine.
Innovations in Liquid Biopsies for Precision Cancer Diagnosis
Precision medicine, with its focus on tailoring medical interventions to individual characteristics, benefits significantly from the integration of machine learning (ML) algorithms for predictive analytics. These algorithms analyze complex datasets, identify patterns, and generate predictions that inform personalized treatment strategies. This article explores the diverse applications of ML in precision medicine, highlighting the key algorithms driving predictive analytics in this transformative field.
Adaptive Clinical Trials: Enhancing Precision and Efficiency
Adaptive clinical trials represent a transformative approach to clinical research, offering unparalleled flexibility, efficiency, and precision. As the scientific community continues to embrace adaptive designs, the landscape of clinical trials is evolving to better meet the challenges of modern drug development. The integration of adaptive methodologies holds the promise of not only expediting the path to effective treatments but also ensuring that the trial process is patient-centered, resource-efficient, and responsive to the dynamic nature of medical research.
Pharmaceutical Industry's Role in Advancing Precision Medicine
The pharmaceutical industry plays a pivotal role in driving advancements in precision medicine, a revolutionary approach that tailors medical treatment to individual patient characteristics. By leveraging cutting-edge technologies, conducting innovative research, and collaborating with diverse stakeholders, the pharmaceutical sector contributes significantly to the development and implementation of precision medicine, ushering in a new era of personalized healthcare.
More from ClinosolIndia (20)
Role of Drug Regulatory agencies in Clinical Research.
Role of Drug Regulatory agencies in Clinical Research.
Introduction to Blogs, Presentations and Review Articles- Noorush Shifa Nizami
Introduction to Blogs, Presentations and Review Articles- Noorush Shifa Nizami
Patient-Centric Approaches in Precision Medicine Trials: Strategies for Success
Patient-Centric Approaches in Precision Medicine Trials: Strategies for Success
Collaborative Initiatives: How Patient Advocacy Groups Contribute to the Succ...
Collaborative Initiatives: How Patient Advocacy Groups Contribute to the Succ...
Ethical Dilemmas in Precision Medicine: Navigating the Intersection of Scienc...
Ethical Dilemmas in Precision Medicine: Navigating the Intersection of Scienc...
Regulatory Considerations in Precision Medicine: Navigating the Approval Process
Regulatory Considerations in Precision Medicine: Navigating the Approval Process
Emerging Technologies and Tools in Precision Medicine Research
Emerging Technologies and Tools in Precision Medicine Research
Precision Medicine in Action: Case Studies and Success Stories
Precision Medicine in Action: Case Studies and Success Stories
Harnessing Big Data and Artificial Intelligence for Pharmacovigilance in Prec...
Harnessing Big Data and Artificial Intelligence for Pharmacovigilance in Prec...
Pharmacovigilance (PV) Companies: Ensuring Drug Safety in Personalized Treatm...
Pharmacovigilance (PV) Companies: Ensuring Drug Safety in Personalized Treatm...
Adoptive Design: Optimizing Clinical Trial Strategies for Precision Medicine
Adoptive Design: Optimizing Clinical Trial Strategies for Precision Medicine
Emerging Technologies Shaping the Future of Precision Medicine
Emerging Technologies Shaping the Future of Precision Medicine
Innovations in Liquid Biopsies for Precision Cancer Diagnosis
Innovations in Liquid Biopsies for Precision Cancer Diagnosis
Adaptive Clinical Trials: Enhancing Precision and Efficiency
Adaptive Clinical Trials: Enhancing Precision and Efficiency
Pharmaceutical Industry's Role in Advancing Precision Medicine
Pharmaceutical Industry's Role in Advancing Precision Medicine
Recently uploaded
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Knee anatomy and clinical tests 2024.pdf
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
KDIGO 2024 guidelines for diabetologists
KDIGO guidelines 2024 for evaluation and management of CKD, related to diabetes and management of diabetic kidney disease
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeProf. Marcus Renato de Carvalho
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Physiology of Chemical Sensation of smell.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
PPT RELATED TO ARTHROLOGY ACCORDING TO NCISM AYURVEDA
Prix Galien International 2024 Forum Program
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Flu Vaccine Alert in Bangalore Karnataka
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Valuable Content of Human Anatomy and Physiology of Urinary system as per PCI Syllabus for Pharmacy and PharmD Students.
Recently uploaded (20)
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Intentional re-challenge and the clinical data management of Drug Related problems
- 1. Welcome Intentional re-challenge and the clinical data management of Drug Related problems MOHAMED SALIH ASLAM B.PHARM Student ID -188/092023 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 1
- 2. CONTENTS • INTRODUCTION • STRATEGIES • IMPORTANCE OF INTENTIONAL RE-CHALLENGE • CLINICAL DATA MANAGEMENT • TOOLS FOR CDM • CDM PROCESS • LIST OF CDM ACTIVITIES • CONCLUSION • REFERENCES 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 2
- 3. INTRODUCTION Intentional Re-challenge: 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 3 Rechallenge refers to the re-administration of a medication suspected of causing an adverse reaction, considering the benefit/risk balance of the medication and alternative treatments. Clinical data management involves meticulously gathering, documenting, and analyzing patient medical history, adverse events, and re-challenges to make informed decisions about drug safety and patient response, a crucial step in evaluating and managing drug- related issues. Clinical data management of Drug Related problems
- 4. STRATEGIES 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 4 ‘Type A’: Drug interactions are a subtype of Type A adverse reactions, requiring a rechallenge test based on pharmacological criteria, involving low dose within therapeutic range or high doses if therapeutic failure occurs. ‘Type B’: Hypersensitivity reactions require a rechallenge test, often based on immunological or metabolic criteria, with low doses. Rechallenge is potentially dangerous. The underlying mechanism is uncertain, and cross hypersensitivity may occur. ‘Type C’: These reactions often have no suggestive time course and may follow neither pharmacological nor immunological principles. For example, increased risk of acquiring a ‘natural’ disease (e.g. myocardial infarction, pulmonary embolism), or increased frequency of a recurrent but transient event (e.g. more frequent migraine or convulsions)
- 5. IMPORTANCE OF INTENTIONAL RE-CHALLANGE 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 5 Causality Confirmation Pharmacov igilance Treatment Decision Patient safety Avoiding Misdiagnosis IMPORTANCE OF INTENTIONAL RE- CHALLANGE
- 6. CLINICAL DATA MANAGEMENT Definition 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 6 The process of collecting, scrubbing, and managing subject data in accordance with regulatory requirements is known as CDM. The primary objective of CDM processes is to provide high- quality data by keeping the number of errors and missing data as low as possible and gather maximum data for analysis. Purpose of CDM ❑ Clinical data management's (CDM) goal is to produce accurate, trustworthy, and statistically sound data from clinical trials. ❑ CDM ensures the collection, integration, and availability of data at appropriate quality and cost. ❑ CDM plays an essential role in the data collection phase of clinical research.
- 7. TOOLS FOR CDM 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 7 ✓ Many software tools are available for data management, and these are called Clinical Data Management Systems (CDMS). ✓ Commonly used CDM tools are ❖ ORACLE CLINICAL ❖ CLINTRIAL ❖ MACRO ❖ RAVE and ❖ eClinical Suite
- 8. THE CDM PROCESS 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 8 ❖ The CDM process is designed to deliver an error-free, valid, and statistically sound database. To meet this objective, the CDM process starts early, even before the finalization of the study protocol.
- 9. 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 9 Review and finalization of study documents ➢ The protocol is reviewed for clarity and consistency, with the CDM team designing a Case Report Form (CRF) to translate protocol-specific activities into data. ➢ The CRF should be concise, self-explanatory, and user-friendly, with clear data fields and units. ➢ Filling instructions (CRF Completion Guidelines) should be provided for error-free data acquisition.
- 10. LIST OF CDM ACTIVITIES 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 10 Database locking Medical coding Discrepancy management Data validation Data entry CRF tracking Data collection Database designing
- 11. 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 11 CRF tracking Logistic way if it is paper based study. EDC-electronic data capture if it is e-CRF Data entry Data entry is a process of entering /transferring data from case report form to clinical data management system (CDMS) Database set up and testing Database setup and testing are always performed in a secure, non -study data environment. Only when a database has been reviewed and fully tested, will it be set in ‘production’, a separate environment where only study data will be entered. Data collection process Gathering of data in the course of trail from patient medical history, initial adverse event details, monitoring during re-challenge, and documentation of outcomes
- 12. 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 12 Discrepancy management Discrepancy management is a process of cleaning subject data in the clinical data management system (CDMS), it includes manual checks and programmed checks.
- 13. 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 13 Database lock The database lock for a study is done to ensure no manipulation of study data during the final analysis Quality control Quality should be maintained for overall study by performing quality checks at intervals for all data points prior to database lock. Medical coding involves identifying and classifying medical terminologies in clinical trials using online medical dictionaries. Knowledge of medical terminology, disease entities, drugs, and pathological processes is required. Customized dictionaries are also used by pharmaceutical companies. Medical coding
- 14. CONCLUSION 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 14 Intentional re-challenge confirms if a drug caused an adverse reaction. Following careful steps and data collection ensures safety and reliable results. This helps diagnose accurately and decide treatments better. Alongside good data management, intentional re-challenge guides healthcare professionals by telling apart real drug reactions from coincidences. This makes treatment plans personal and boosts patient safety.
- 15. REFERENCES ▪ Meyboom, R. Intentional Rechallenge and the Clinical Management of Drug-Related Problems. Drug Saf 36, 163–165 (2013). ▪ https://doi.org/10.1007/s40264-013-0023-0 ▪ https://www.clinion.com/insight/clinical-data-management-whatare- the-key-challenges/ ▪ Stephens M. "Deliberate Drug Rechallenge." Human Toxicology. 1983;2(4):573-577. doi:10.1177/096032718300200401 ▪ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326906/ 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 15
- 16. Thank You! www.clinosol.com (India | Canada) 9121151622/623/624 info@clinosol.com 10/18/2022 www.clinosol.com | follow us on social media @clinosolresearch 16